Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 3Sarcoma 2Ovarian Neoplasms 2Oligodendroglioma 2Neoplasm Metastasis 2Gliosarcoma 2Glioblastoma 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Brain Neoplasms 2Astrocytoma 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Somatostatinoma 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Glioma 1Fibrolamellar hepatocellular carcinoma 1Endometrial Neoplasms 1

Interventions

Specimen Handling 6cabozantinib 4Magnetic Resonance Spectroscopy 4Trastuzumab 3Gemcitabine 3Biopsy 3eribulin 2atezolizumab 2Nivolumab 2Ipilimumab 2CTLA-4 Antigen 2tipifarnib 1pazopanib 1ixabepilone 1erdafitinib 1entinostat 1enfortumab vedotin 1avelumab 1aflibercept 1Sunitinib 1Sorafenib 1Platinum 1Lenalidomide 1Interleukin-7 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunohistochemistry 1Immunoglobulin G 1Fluorouracil 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Urethral Neoplasms × aflibercept × Clear all
NCT00407485 2014-10-20

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

National Cancer Institute (NCI)

Phase 2 Completed
22 enrolled 7 charts
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡